{"id":"https://openalex.org/W3013350468","doi":"https://doi.org/10.1007/s40268-020-00301-8","title":"Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond","display_name":"Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond","publication_year":2020,"publication_date":"2020-03-25","ids":{"openalex":"https://openalex.org/W3013350468","doi":"https://doi.org/10.1007/s40268-020-00301-8","mag":"3013350468","pmid":"https://pubmed.ncbi.nlm.nih.gov/32215876","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7221042"},"language":"en","primary_location":{"id":"doi:10.1007/s40268-020-00301-8","doi":"https://doi.org/10.1007/s40268-020-00301-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40268-020-00301-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40268-020-00301-8.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40268-020-00301-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057565228","display_name":"Stergios Boussios","orcid":"https://orcid.org/0000-0002-2512-6131","observed_orcids":["https://orcid.org/0000-0002-2512-6131"]},"institutions":[{"id":"https://openalex.org/I4210104168","display_name":"Medway NHS Foundation Trust","ror":"https://ror.org/01apxt611","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Stergios Boussios","raw_affiliation_strings":["AELIA Organization, 9th Km Thessaloniki - Thermi, 57001, Thessaloniki, Greece. stergiosboussios@gmail.com","Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK. stergiosboussios@gmail.com","Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AELIA Organization, 9th Km Thessaloniki - Thermi, 57001, Thessaloniki, Greece. stergiosboussios@gmail.com","institution_ids":[]},{"raw_affiliation_string":"Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK. stergiosboussios@gmail.com","institution_ids":["https://openalex.org/I4210104168"]},{"raw_affiliation_string":"Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK","institution_ids":["https://openalex.org/I4210104168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045382346","display_name":"Charlotte Abson","orcid":"https://orcid.org/0000-0002-6601-438X","observed_orcids":["https://orcid.org/0000-0002-6601-438X"]},"institutions":[{"id":"https://openalex.org/I150517883","display_name":"Maidstone and Tunbridge Wells NHS Trust","ror":"https://ror.org/02yq33n72","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I150517883"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Abson","raw_affiliation_strings":["Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Hermitage Lane, Maidstone, Kent, ME16 9QQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Hermitage Lane, Maidstone, Kent, ME16 9QQ, UK","institution_ids":["https://openalex.org/I150517883"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059943491","display_name":"Michele Moschetta","orcid":"https://orcid.org/0000-0003-4370-1723","observed_orcids":["https://orcid.org/0000-0003-4370-1723"]},"institutions":[{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michele Moschetta","raw_affiliation_strings":["Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge, CB2 0QQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge, CB2 0QQ, UK","institution_ids":["https://openalex.org/I2802466933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029091749","display_name":"Elie Rassy","orcid":"https://orcid.org/0000-0002-7906-0991","observed_orcids":["https://orcid.org/0000-0002-7906-0991"]},"institutions":[{"id":"https://openalex.org/I184679254","display_name":"Saint Joseph University","ror":"https://ror.org/044fxjq88","country_code":"LB","type":"education","lineage":["https://openalex.org/I184679254"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4210152906","display_name":"H\u00f4tel-Dieu de France","ror":"https://ror.org/04w1m5n60","country_code":"LB","type":"healthcare","lineage":["https://openalex.org/I4210152906"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR","LB"],"is_corresponding":false,"raw_author_name":"Elie Rassy","raw_affiliation_strings":["Department of Cancer Medicine, Gustave Roussy Institut, Villejuif, France","Department of Hematology-Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Medicine, Gustave Roussy Institut, Villejuif, France","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]},{"raw_affiliation_string":"Department of Hematology-Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon","institution_ids":["https://openalex.org/I184679254","https://openalex.org/I4210152906"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002817573","display_name":"Afroditi Karathanasi","orcid":"https://orcid.org/0000-0003-0273-1723","observed_orcids":["https://orcid.org/0000-0003-0273-1723"]},"institutions":[{"id":"https://openalex.org/I4210104168","display_name":"Medway NHS Foundation Trust","ror":"https://ror.org/01apxt611","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Afroditi Karathanasi","raw_affiliation_strings":["Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK","institution_ids":["https://openalex.org/I4210104168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032154272","display_name":"Tahir Bhat","orcid":"https://orcid.org/0000-0002-4501-5340","observed_orcids":["https://orcid.org/0000-0002-4501-5340"]},"institutions":[{"id":"https://openalex.org/I4210104168","display_name":"Medway NHS Foundation Trust","ror":"https://ror.org/01apxt611","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tahir Bhat","raw_affiliation_strings":["Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK","institution_ids":["https://openalex.org/I4210104168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055922591","display_name":"Faisal Iftikhar Ahmed Ghumman","orcid":"https://orcid.org/0000-0001-6820-0058","observed_orcids":["https://orcid.org/0000-0001-6820-0058"]},"institutions":[{"id":"https://openalex.org/I4210104168","display_name":"Medway NHS Foundation Trust","ror":"https://ror.org/01apxt611","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Faisal Ghumman","raw_affiliation_strings":["Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK","institution_ids":["https://openalex.org/I4210104168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016163128","display_name":"Matin Sheriff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104168","display_name":"Medway NHS Foundation Trust","ror":"https://ror.org/01apxt611","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matin Sheriff","raw_affiliation_strings":["Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent, ME7 5NY, UK","institution_ids":["https://openalex.org/I4210104168"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063853321","display_name":"Nicholas A. Pavlidis","orcid":"https://orcid.org/0000-0002-2195-9961","observed_orcids":["https://orcid.org/0000-0002-2195-9961"]},"institutions":[{"id":"https://openalex.org/I194019607","display_name":"University of Ioannina","ror":"https://ror.org/01qg3j183","country_code":"GR","type":"education","lineage":["https://openalex.org/I194019607"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Nicholas Pavlidis","raw_affiliation_strings":["Medical School, University of Ioannina, Stavros Niarchou Avenue, 45110, Ioannina, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical School, University of Ioannina, Stavros Niarchou Avenue, 45110, Ioannina, Greece","institution_ids":["https://openalex.org/I194019607"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5057565228"],"corresponding_institution_ids":["https://openalex.org/I4210104168"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":2.5387,"has_fulltext":true,"cited_by_count":142,"citation_normalized_percentile":{"value":0.92687773,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"20","issue":"2","first_page":"55","last_page":"73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9900000095367432},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9380000233650208},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9369999766349792},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.8420000076293945},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9589999914169312},{"id":"https://openalex.org/keywords/dna-repair-deficiency","display_name":"DNA repair deficiency","score":0.8619999885559082},{"id":"https://openalex.org/keywords/brcaness","display_name":"BRCAness","score":0.7789999842643738},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.8859999775886536},{"id":"https://openalex.org/keywords/rucaparib","display_name":"rucaparib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/niraparib","display_name":"niraparib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/veliparib","display_name":"veliparib","score":0.9319999814033508},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5929999947547913},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7070000171661377},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.781000018119812},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.746999979019165},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.5429999828338623},{"id":"https://openalex.org/keywords/side-effect-profile","display_name":"side effect profile","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.8583587408065796},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.737663209438324},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6700179576873779},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4874425232410431},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41757437586784363},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41406381130218506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.360178679227829},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35291188955307007},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3381381630897522},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.23719266057014465},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1634036898612976}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011065","descriptor_name":"Poly(ADP-ribose) Polymerases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":8,"locations":[{"id":"doi:10.1007/s40268-020-00301-8","doi":"https://doi.org/10.1007/s40268-020-00301-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40268-020-00301-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40268-020-00301-8.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"journal-article"},{"id":"pmid:32215876","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32215876","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7221042","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7221042/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs R D","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:d86397648f6f4e27a7986f7cef885935","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d86397648f6f4e27a7986f7cef885935","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drugs in R&D, Vol 20, Iss 2, Pp 55-73 (2020)","raw_type":"article"},{"id":"pmh:oai:www.repository.cam.ac.uk:1810/306532","doi":null,"is_oa":true,"landing_page_url":"https://www.repository.cam.ac.uk/handle/1810/306532","pdf_url":null,"source":{"id":"https://openalex.org/S4306401777","display_name":"Apollo (University of Cambridge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I241749","host_organization_name":"University of Cambridge","host_organization_lineage":["https://openalex.org/I241749"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:www.repository.cam.ac.uk:1810/319210","doi":null,"is_oa":true,"landing_page_url":"https://www.repository.cam.ac.uk/handle/1810/319210","pdf_url":null,"source":{"id":"https://openalex.org/S4306401777","display_name":"Apollo (University of Cambridge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I241749","host_organization_name":"University of Cambridge","host_organization_lineage":["https://openalex.org/I241749"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"doi:10.17863/cam.53612","doi":"https://doi.org/10.17863/cam.53612","is_oa":true,"landing_page_url":"https://doi.org/10.17863/cam.53612","pdf_url":null,"source":{"id":"https://openalex.org/S7407050737","display_name":"Apollo","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.17863/cam.66330","doi":"https://doi.org/10.17863/cam.66330","is_oa":true,"landing_page_url":"https://doi.org/10.17863/cam.66330","pdf_url":null,"source":{"id":"https://openalex.org/S7407050737","display_name":"Apollo","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1007/s40268-020-00301-8","doi":"https://doi.org/10.1007/s40268-020-00301-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40268-020-00301-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40268-020-00301-8.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3013350468.pdf","grobid_xml":"https://content.openalex.org/works/W3013350468.grobid-xml"},"referenced_works_count":101,"referenced_works":["https://openalex.org/W1839388921","https://openalex.org/W1970211011","https://openalex.org/W1973268287","https://openalex.org/W1984629445","https://openalex.org/W1986471561","https://openalex.org/W1989006164","https://openalex.org/W2002962154","https://openalex.org/W2006778039","https://openalex.org/W2009007206","https://openalex.org/W2024254896","https://openalex.org/W2039855253","https://openalex.org/W2055904567","https://openalex.org/W2075430338","https://openalex.org/W2083693467","https://openalex.org/W2084833108","https://openalex.org/W2086038769","https://openalex.org/W2090740451","https://openalex.org/W2095787833","https://openalex.org/W2096136751","https://openalex.org/W2097027640","https://openalex.org/W2097982052","https://openalex.org/W2098737737","https://openalex.org/W2100419317","https://openalex.org/W2102004732","https://openalex.org/W2111437716","https://openalex.org/W2111900617","https://openalex.org/W2112241575","https://openalex.org/W2114021402","https://openalex.org/W2117177285","https://openalex.org/W2117964602","https://openalex.org/W2123113463","https://openalex.org/W2130078242","https://openalex.org/W2134259738","https://openalex.org/W2135525536","https://openalex.org/W2137755195","https://openalex.org/W2142658272","https://openalex.org/W2147154862","https://openalex.org/W2151509048","https://openalex.org/W2152061559","https://openalex.org/W2153579158","https://openalex.org/W2157899948","https://openalex.org/W2168893449","https://openalex.org/W2179105349","https://openalex.org/W2204866603","https://openalex.org/W2216554257","https://openalex.org/W2294633761","https://openalex.org/W2367214440","https://openalex.org/W2416684375","https://openalex.org/W2462985846","https://openalex.org/W2472306545","https://openalex.org/W2500891884","https://openalex.org/W2520031340","https://openalex.org/W2531736191","https://openalex.org/W2539944286","https://openalex.org/W2556688586","https://openalex.org/W2557666746","https://openalex.org/W2570618306","https://openalex.org/W2592941899","https://openalex.org/W2593067736","https://openalex.org/W2596164112","https://openalex.org/W2610261021","https://openalex.org/W2610368132","https://openalex.org/W2613362156","https://openalex.org/W2621271973","https://openalex.org/W2627871710","https://openalex.org/W2704159227","https://openalex.org/W2724857992","https://openalex.org/W2737389832","https://openalex.org/W2744945030","https://openalex.org/W2751912349","https://openalex.org/W2754775344","https://openalex.org/W2757586983","https://openalex.org/W2766552679","https://openalex.org/W2788106879","https://openalex.org/W2789900707","https://openalex.org/W2795391593","https://openalex.org/W2796336849","https://openalex.org/W2805187906","https://openalex.org/W2806421431","https://openalex.org/W2808113406","https://openalex.org/W2810070440","https://openalex.org/W2811158315","https://openalex.org/W2886477543","https://openalex.org/W2892812402","https://openalex.org/W2897100510","https://openalex.org/W2897751981","https://openalex.org/W2904394271","https://openalex.org/W2908112515","https://openalex.org/W2935541805","https://openalex.org/W2946351532","https://openalex.org/W2947267471","https://openalex.org/W2961496023","https://openalex.org/W2965145700","https://openalex.org/W2970135300","https://openalex.org/W2970401899","https://openalex.org/W2975141952","https://openalex.org/W2976139792","https://openalex.org/W2977575205","https://openalex.org/W2978453562","https://openalex.org/W2981585441","https://openalex.org/W2989612821"],"related_works":["https://openalex.org/W2923502471","https://openalex.org/W3184156379","https://openalex.org/W7160329579","https://openalex.org/W2588625168","https://openalex.org/W4313368192","https://openalex.org/W2912552370","https://openalex.org/W2992135268","https://openalex.org/W2964041717","https://openalex.org/W2955987142","https://openalex.org/W3134914296"],"abstract_inverted_index":{"Genetic":[0],"complexity":[1],"and":[2,13,32,84,93,115,168,186,189,192,198],"DNA":[3,26,69,79],"damage":[4,70],"repair":[5,27,80],"defects":[6,23],"are":[7],"common":[8],"in":[9,24,40,74,98,134,171,190,201],"different":[10],"cancer":[11,48],"types":[12],"can":[14],"induce":[15],"tumor-specific":[16],"vulnerabilities.":[17],"Poly(ADP-ribose)":[18],"polymerase":[19],"(PARP)":[20],"inhibitors":[21,58,89],"exploit":[22],"the":[25,54,75,99,121,125,159,172],"pathway":[28],"through":[29],"synthetic":[30],"lethality":[31],"have":[33],"emerged":[34,164],"as":[35],"promising":[36],"anticancer":[37],"therapies,":[38,188],"especially":[39],"tumors":[41],"harboring":[42],"deleterious":[43],"germline":[44,63,129],"or":[45],"somatic":[46],"breast":[47,132],"susceptibility":[49],"gene":[50],"(BRCA)":[51],"mutations.":[52],"However,":[53],"utility":[55],"of":[56,77,102,127,174],"PARP":[57,88,107,152],"could":[59],"be":[60],"expanded":[61],"beyond":[62],"BRCA1/2":[64,130],"mutated":[65,131],"cancers":[66,133],"by":[67,120],"causing":[68],"with":[71,183,203],"cytotoxic":[72],"agents":[73],"presence":[76],"a":[78],"inhibitor.":[81],"US":[82,122],"Food":[83],"Drug":[85],"Administration":[86],"(FDA)-approved":[87],"include":[90,179],"olaparib,":[91],"rucaparib,":[92],"niraparib,":[94],"while":[95],"veliparib":[96],"is":[97],"late":[100],"stage":[101],"clinical":[103,169],"development.":[104],"Talazoparib":[105],"inhibits":[106],"catalytic":[108],"activity,":[109],"trapping":[110],"PARP1/2":[111],"on":[112],"damaged":[113],"DNA,":[114],"it":[116],"has":[117,163],"been":[118],"approved":[119,151],"FDA":[123],"for":[124,195],"treatment":[126],"metastatic":[128],"October":[135],"2018.":[136],"The":[137],"talazoparib":[138],"side":[139],"effect":[140],"profile":[141],"more":[142],"closely":[143],"resembles":[144],"traditional":[145],"chemotherapeutics":[146],"rather":[147],"than":[148],"other":[149],"clinically":[150],"inhibitors.":[153],"In":[154],"this":[155],"review,":[156],"we":[157],"discuss":[158],"scientific":[160],"evidence":[161],"that":[162],"from":[165],"both":[166],"experimental":[167],"studies":[170],"development":[173],"talazoparib.":[175],"Future":[176],"directions":[177],"will":[178],"optimizing":[180],"combination":[181],"therapy":[182],"chemotherapy,":[184],"immunotherapies":[185],"targeted":[187],"developing":[191],"validating":[193],"biomarkers":[194],"patient":[196],"selection":[197],"stratification,":[199],"particularly":[200],"malignancies":[202],"'BRCAness'.":[204]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":21},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":32},{"year":2020,"cited_by_count":16}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2020-04-03T00:00:00"}